3238
H. Brunner, M. Prommesberger / Tetrahedron: Asymmetry 9 (1998) 3231–3239
6. Experimental
2-Butyl-4,7-dihydro-1,3-dioxepin29 and 2-butyl-4,5-dihydro-1,3-dioxepin30 were prepared by litera-
ture methods. 2-Butyl-1,3-dioxepan: synthesis similar to 2-n-butyl-4,7-dihydro-1,3-dioxepin from valer-
aldehyde (21.2 ml, 200 mmol) and 1,4-butanediol (19.4 ml, 220 mmol). Yield 22.4 g (71%). B.p.
87–89°C/20 torr. IR (KBr): 2939, 2871 cm−1 (νC–H). 1H NMR (250 MHz, CDCl3): 4.64 (t, 3J=5.7, 1H,
H2), 3.93–3.84 (m, 2H, H4, H7), 3.66–3.55 (m, 2H, H4, H7), 1.73–1.51 (m, 6H, H5, H6, O2CHCH2),
1.36–1.28 (m, 4H, CH2CH2CH2CH3), 0.91–0.85 (m, 3H, CH3). Anal. calcd for C9H18O2 (158.24): C,
68.31; H, 11.47. Found: C, 68.19; H, 11.27. EI MS: m/z (%)=158 (M, 1), 101 (100), 71 (30), 55 (87), 41
(11).
The catalytic isomerizations were carried out under an atmosphere of dry nitrogen. The catalyst (0.05
mmol) was dissolved in the appropriate solvent (6 ml). NaBH4 (50.0 mmol) was added followed by 2-
n-butyl-4,7-dihydro-1,3-dioxepin (10.0 mmol). The developing hydrogen was removed by a stream of
nitrogen for ca. 15 min. After 24 h, the reaction was stopped by bubbling air through the solution and the
solvent was evaporated. The oily residue was purified by Kugelrohr distillation (60°C, 2 torr). Conversion
1
was determined by H NMR spectrocopy (250 MHz, CDCl3). The integrals of the following signals
were used: starting material A: multiplet (δ=5.7 ppm), product B: doublet of doublets (δ=6.4 ppm),
hydrogenation product C: multiplet (δ=3.5–3.9 ppm). The enantiomeric analysis was carried out by GC:
HP 5890 A and HP 5890 II, respectively. Method 1 (used for most of the catalyses): Macherey–Nagel
Lipodex C column (50 m, 0.25 mm ID). Conditions: carrier gas H2, 1.5 bar, 35°C isothermal. Retention
times for the enantiomers of B 124.5 and 129.1 min and the hydrogenation product C 121.2 min. Method
2: Restek Rt-βDEXcst column (30 m, 0.32 mm ID). Conditions: carrier gas H2, 0.7 bar, 82°C isothermal.
Retention times for the enantiomers of B 15.5 and 16.3 min and the hydrogenation product C 17.2 min.
References
1. H. Brunner, B. Nuber, G. Olschewski, Synthesis, submitted.
2. H. Frauenrath, T. Philipps, Angew. Chem. 1986, 98, 261; Angew. Chem., Int. Ed. Engl. 1986, 25, 274.
3. H. Frauenrath, S. Reim, A. Wiesner, Tetrahedron: Asymmetry 1998, 9, 1103.
4. M. Prommesberger, Ph.D. Thesis, Universität Regensburg, 1998.
5. H. Brunner, Acc. Chem. Res. 1979, 12, 250.
6. H. Brunner, Adv. Organomet. Chem. 1980, 18, 152.
7. H. Brunner, Angew. Chem. 1983, 95, 921; Angew. Chem., Int. Ed. Engl. 1983, 22, 897.
8. H. Brunner, Angew. Chem., in press.
9. For the use of (η6-arene)ruthenium half-sandwich complexes as catalyst precursors see Refs. 2–4 of the preceding paper.
10. H. Brunner, R. G. Gastinger, J. Chem. Soc., Chem. Commun. 1977, 488.
11. S. K. Mandal, A. R. Chakravarty, J. Organomet. Chem. 1991, 417, C59.
12. S. K. Mandal, A. R. Chakravarty, J. Chem. Soc., Dalton Trans. 1992, 1627.
13. S. K. Mandal, A. R. Chakravarty, Inorg. Chem. 1993, 32, 3851.
14. H. Brunner, R. Oeschey, B. Nuber, Angew. Chem. 1994, 106, 941; Angew. Chem., Int. Ed. Engl. 1994, 33, 866.
15. H. Brunner, R. Oeschey, Inorg. Chem. 1995, 34, 3349.
16. H. Brunner, R. Oeschey, B. Nuber, J. Chem. Soc., Dalton Trans. 1996, 1499.
17. H. Brunner, R. Oeschey, B. Nuber, Organometallics 1996, 15, 3616.
18. H. Brunner, R. Oeschey, B. Nuber, J. Organomet. Chem. 1996, 518, 47.
19. D. Enders, H. Gielen, G. Raabe, J. Rusinsk, J. H. Teles, Chem. Ber./Recueil 1997, 130, 1253.
20. D. L. Davies, J. Fawcett, R. Kratczyk, D. R. Russell, J. Organomet. Chem. 1997, 545–546, 581.
21. J. Halpern, in Asymmetric Synthesis, Vol. 5; J. D. Morrison, Ed.; Academic Press: Orlando, 1985; p. 41.
22. D. Carmona, C. Cativiela, S. Elipe, F. J. Lahoz, M. P. Lamata, M. Pilar, L.-R. de Víu, L. A. Oro, C. Vega, F. Viguri, J.
Chem. Soc., Chem. Commun. 1997, 2351.